Gene · 65057
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A human embryonic limb cell atlas resolved in space and time. | Nature | 2024 | 38057666 | PubTator, text mining | PubMed |
| AAACH is a conserved motif in a cis-acting replication element that is artificially inserted into Senecavirus A genome. | Virus Res | 2024 | 37952688 | PubTator, text mining | PubMed |
| Wireless electrical-molecular quantum signalling for cancer cell apoptosis. | Nat Nanotechnol | 2024 | 37709951 | PubTator, text mining | PubMed |
| Synergistic effects of complex drug combinations in colorectal cancer cells predicted by logical modelling. | Front Syst Biol | 2023 | 40809499 | PubTator, text mining | PubMed |
| Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer. | Front Oncol | 2023 | 38269020 | PubTator, text mining | PubMed |
| RNA-Seq Analysis of Trans-Differentiated ARPE-19 Cells Transduced by AAV9-AIPL1 Vectors. | Int J Mol Sci | 2023 | 38203368 | PubTator, text mining | PubMed |
| Never-Ending Story: New Cyclodextrin-Based Metal-Organic Framework Crystal Structures Obtained Using Different Crystallization Methods. | ACS Omega | 2023 | 38144108 | PubTator, text mining | PubMed |
| Rapid Discovery of Substances with Anticancer Potential from Marine Fungi Based on a One Strain-Many Compounds Strategy and UPLC-QTOF-MS. | Mar Drugs | 2023 | 38132967 | PubTator, text mining | PubMed |
| Exploration of the Conformational Scenario for α-, β-, and γ-Cyclodextrins in Dry and Wet Conditions, from Monomers to Crystal Structures: A Quantum-Mechanical Study. | Int J Mol Sci | 2023 | 38069149 | PubTator, text mining | PubMed |
| Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations. | Front Cell Dev Biol | 2023 | 38033865 | PubTator, text mining | PubMed |
| Genomic analysis of a Palestinian family with inherited cancer syndrome: a next-generation sequencing study. | Front Genet | 2023 | 38028607 | PubTator, text mining | PubMed |
| Artificial Intelligence in Ophthalmic Surgery: Current Applications and Expectations. | Clin Ophthalmol | 2023 | 38026589 | PubTator, text mining | PubMed |
| Preparation and temperature-controlled morphology of helical microrods composed of supramolecular α-cyclodextrin assemblies. | RSC Adv | 2023 | 38024982 | PubTator, text mining | PubMed |
| Preparation and Application of Polyrotaxane Cross-Linking Agent Based on Cyclodextrin in Gel Materials Field. | Gels | 2023 | 37998944 | PubTator, text mining | PubMed |
| Genome-wide transcriptional profiling and physiological investigation elucidating the molecular mechanism of multiple abiotic stress response in Stevia rebaudiana Bertoni. | Sci Rep | 2023 | 37963906 | PubTator, text mining | PubMed |
| Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? | J Clin Med | 2023 | 37959410 | PubTator, text mining | PubMed |
| Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients. | Int J Mol Sci | 2023 | 37958811 | PubTator, text mining | PubMed |
| Supramolecular nanomedicines based on host-guest interactions of cyclodextrins. | Exploration (Beijing) | 2023 | 37933241 | PubTator, text mining | PubMed |
| Updated conclusion on the peer review of the pesticide risk assessment of the active substance mecoprop-P. | EFSA J | 2023 | 37901692 | PubTator, text mining | PubMed |
| Multiple Primary Melanoma: A Five-Year Prospective Single-Center Follow-Up Study of Two MC1R R/R Genotype Carriers. | Life (Basel) | 2023 | 37895483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/65057/papers?page=5